Clarifying the Tamiflu “shortage”
On October 23rd, members of the CIPA, IPA BC and MIPA met with members of Health Canada in Ottawa to discuss with the implementation of legislation and regulation that will affect the future of IPS practice. This meeting corresponded with recent media focus on the supply and distribution of Tamiflu.
Currently, newspaper, television and radio are incorrectly blaming current IPS practices for the alleged shortage of the Tamiflu anti-viral medication. Despite the fact that the Canadian government clearly states that a sufficient supply of Tamiflu for Canadians is already stockpiled, the CPHA, OPA and other organizations are using the media attention surrounding Tamiflu as a platform against the export of pharmaceuticals from Canada.
In spite of the Canadian government’s assertion that there is no shortage of Tamiflu for Canadians, DoctorSolve will no longer offer Tamiflu on our Web site. This show of good faith is the only way to demonstrate our commitment to a “Canadians First” policy.